Stay updated on Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial
Sign up to get notified when there's something new on the Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial page.

Latest updates to the Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial page
- Check3 days agoChange DetectedNew entries were added to the Record History, including a Revision: v3.3.4 entry and several 2026-01-XX date stamps tied to the Study Status. This appears to be a minor system update to the history page.SummaryDifference0.1%

- Check10 days agoChange DetectedAdded new history entries for versions 944–948 dated 2026-01-02 to 2026-01-09, primarily updating Study Status and Contacts/Locations, and removed the 2025-11-19 entry.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedAdded Revision: v3.3.3 to the version history. Removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the history.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page's Record History shows an added Revision: v3.3.2 and removal of Revision: v3.3.1, indicating a minor site release update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check60 days agoChange DetectedAdded entries for Study Status and Contacts/Locations, and updated the record revision to v3.3.1 (replacing the previous v3.2.0).SummaryDifference0.0%

- Check67 days agoChange DetectedThe only visible change is the removal of a site-wide notice about government funding status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial page.